DNA-based genetic testing kit manufacturer Elucigene Diagnostics has taken 8,000 sq ft in Manchester Science Partnerships' Citylabs off Oxford Road.
The business has outgrown its original base within MSP's MedTech Centre and required larger, purpose-built lab facilities at Citylabs. Around 75% of the company's revenue comes from exports, with Elucigene now looking to expand into new markets and increase head count.
The space will be used for specialist R&D projects and will house the company's growing team of 20 specialists, which includes a number of postgraduates and graduates.
Citylabs is the £25m redevelopment of the former Manchester Royal Eye Hospital, part-funded by the European Regional Development Fund. The building is a 100,000 sq ft purpose-built biomedical centre within the Central Manchester University Hospitals Trust campus.
Scott Higgins, managing director of Elucigene Diagnostics, said: "We want to grow and develop Elucigene as the leading developer and supplier of genetic analysis assays for clinical use. Mike and I identified a niche in the marketplace and we have been able to make great progress in just two years. Throughout the development of Elucigene Diagnostics, MSP has always been on hand to offer us real support and it has been a valuable collaboration that has taken us to this point."